Anti-GLK antibody - N-terminal

• Supplier: Abcam
• Catalog: ab37796
• Prices: $398.00
• Sizes: 400 µl
• Host: Rabbit
• Clonality: Polyclonal
• Isotype: IgG
• Applications: ELISA ICC/IF ICC/IF WB IHC-P
• Species Reactivities: Mouse, Rat, Human, Pig, Marmoset
• Antigen: Synthetic peptide conjugated to KLH, corresponding to N terminal amino acids and derived from within residues 1-100 of IGLK (Human)(Peptide available as ab108095
• Blocking Peptide: GLK peptide
• Description: Rabbit Polyclonal
• Gene: GCK
• Conjugate: Unconjugated

Product images

All lanes : Anti-GLK antibody - N-terminal (ab37796)Lane 1 : Hep G2 cell lysateLane 2 : Mouse liver lysate

Formalin fixed, paraffin embedded human breast carcinoma tissue using ab37796, followed by AEC staining.

ICC/IF image of ab37796 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab37796, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Product References

1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism - 1-deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism

Li YG, Ji DF, Zhong S, Lin TB, Lv ZQ, Hu GY, Wang X. Sci Rep. 2013;3:1377.

Cooperative anti-diabetic effects of deoxynojirimycin-polysaccharide by - Cooperative anti-diabetic effects of deoxynojirimycin-polysaccharide by

Li YG, Ji DF, Zhong S, Lv ZQ, Lin TB. PLoS One. 2013 Jun 6;8(6):e65892.

Ultrastructural analysis, zinc transporters, glucose transporters and hormones - Ultrastructural analysis, zinc transporters, glucose transporters and hormones

Mohanasundaram D, Drogemuller C, Brealey J, Jessup CF, Milner C, Murgia C, Lang CJ, Milton A, Zalewski PD, Russ GR, Coates PT. Gen Comp Endocrinol. 2011 Nov 1;174(2):71-9.

Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose - Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose

Rafacho A, Marroqui L, Taboga SR, Abrantes JL, Silveira LR, Boschero AC, Carneiro EM, Bosqueiro JR, Nadal A, Quesada I. Endocrinology. 2010 Jan;151(1):85-95.

Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for - Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for

Leibiger B, Moede T, Uhles S, Barker CJ, Creveaux M, Domin J, Berggren PO, Leibiger IB. FASEB J. 2010 Jun;24(6):1824-37.

PGC-1alpha coactivates estrogen-related receptor-alpha to induce the expression - PGC-1alpha coactivates estrogen-related receptor-alpha to induce the expression

Zhu LL, Liu Y, Cui AF, Shao D, Liang JC, Liu XJ, Chen Y, Gupta N, Fang FD, Chang YS. Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1210-8. doi:

Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin - Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin

Ronnebaum SM, Joseph JW, Ilkayeva O, Burgess SC, Lu D, Becker TC, Sherry AD, Newgard CB. J Biol Chem. 2008 May 23;283(21):14248-56.